Methods Hepatitis B serum markers and Pre-S2 antigens were tested by enzyme-linked immunosorbent assay and HBV DNA was detected by fluorescent quantitative-PCR in 982 hepatitis B patients.

The inventive compositions can comprise a combination of the hepatitis B antigen and other coadministered antigens.